Publication | Closed Access

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

Phase 1BMultiple DosesMedicinePharmacotherapySemaglutide 2·4Pharmacology